Search Results - "Lauko, Adam"

Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.

Authors: Lauko, Adam Kotecha, Rupesh Barnett, Addison et al.

Source: Scientific Reports. 9/13/2021, Vol. 11 Issue 1, p1-8. 8p.

Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.

Authors: Lauko, Adam Thapa, Bicky Sharma, Mayur et al.

Source: Scientific Reports. 4/5/2021, Vol. 11 Issue 1, p1-9. 9p.

Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors.

Authors: Lauko, Adam Lo, Alice Ahluwalia, Manmeet S. et al.

Source: Seminars in Cancer Biology. Jul2022, Vol. 82, p162-175. 14p.

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.

Authors: Lauko, Adam Thapa, Bicky Sharma, Mayur et al.

Source: Scientific Reports. 1/18/2022, Vol. 12 Issue 1, p1-1. 1p.

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.

Authors: Lauko, Adam Kotecha, Rupesh Barnett, Addison et al.

Source: Scientific Reports. 1/17/2022, Vol. 12 Issue 1, p1-1. 1p.

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.

Authors: Lauko, Adam Thapa, Bicky Sharma, Mayur et al.

Source: Scientific Reports. 9/8/2021, Vol. 11 Issue 1, p1-1. 1p.

Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles.

Authors: Bayik, Defne Lauko, Adam J. Roversi, Gustavo A. et al.

Source: Scientific Reports. 11/2/2020, Vol. 10 Issue 1, pN.PAG-N.PAG. 1p.

Safety of allogeneic hematopoietic stem cell transplantation in beta‐thalassemia patients with chronic hepatitis C infections treated at a pediatric center.

Authors: Ramgopal, Archana Lauko, Adam Rotz, Seth et al.

Source: Pediatric Transplantation. Sep2019, Vol. 23 Issue 6, pN.PAG-N.PAG. 1p.

361 WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.

Authors: Hubert, Christopher Mitchell, Kelly Sprowls, Samuel et al.

Source: Journal of Clinical & Translational Science; 2023 Supplement 1, Vol. 7, p107-107, 1p

SerpinB3 Drives Cancer Stem Cell Survival In Glioblastoma

Authors: Lauko, Adam

Advisors: Lathia, Justin

Committee Members: Jackson, Mark

URL: http://rave.ohiolink.edu/etdc/view?acc_num=case1649261228109046

Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review.

Authors: Jarmula J Lee J Lauko A et al.

Source: Neuro-oncology advances [Neurooncol Adv] 2024 Aug 10; Vol. 6 (1), pp. vdae142. Date of Electronic Publication: 2024 Aug 10 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

JAM-A functions as a female microglial tumor suppressor in glioblastoma.

Authors: Turaga SM Silver DJ Bayik D et al.

Source: Neuro-oncology [Neuro Oncol] 2020 Nov 26; Vol. 22 (11), pp. 1591-1601.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.

Authors: Lee J Nicosia M Hong ES et al.

Source: Cancer discovery [Cancer Discov] 2023 Sep 06; Vol. 13 (9), pp. 2090-2105.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.

Authors: Alban TJ Bayik D Otvos B et al.

Source: Frontiers in immunology [Front Immunol] 2020 Jun 18; Vol. 11, pp. 1191. Date of Electronic Publication: 2020 Jun 18 (Print Publication: 2020).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.

Authors: Volovetz J Berezovsky AD Alban T et al.

Source: Cell death & disease [Cell Death Dis] 2020 Feb 26; Vol. 11 (2), pp. 152. Date of Electronic Publication: 2020 Feb 26.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.

Authors: Alban TJ Grabowski MM Otvos B et al.

Source: JCI insight [JCI Insight] 2023 Jul 10; Vol. 8 (13). Date of Electronic Publication: 2023 Jul 10.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

Correction: Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.

Authors: Bayik D Bartels CF Lovrenert K et al.

Source: Cancer research [Cancer Res] 2023 May 15; Vol. 83 (10), pp. 1757.

Publication Type: Published Erratum

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE; PubMed not MEDLINE

GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.

Authors: Watson DC Bayik D Storevik S et al.

Source: Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 648-664. Date of Electronic Publication: 2023 May 11.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins.

Authors: Grabowski MM Watson DC Chung K et al.

Source: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Mar 09. Date of Electronic Publication: 2023 Mar 09.

Publication Type: Preprint; Journal Article

Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.

Authors: Mitchell K Sprowls SA Arora S et al.

Source: Genes & development [Genes Dev] 2023 Feb 01; Vol. 37 (3-4), pp. 86-102. Date of Electronic Publication: 2023 Feb 02.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 8711660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-5477 (Electronic) Linking ISSN: 08909369 NLM ISO Abbreviation: Genes Dev Subsets: MEDLINE